Cargando…

Data privacy protection in scientific publications: process implementation at a pharmaceutical company

BACKGROUND: Sharing anonymized/de-identified clinical trial data and publishing research outcomes in scientific journals, or presenting them at conferences, is key to data-driven scientific exchange. However, when data from scientific publications are linked to other publicly available personal info...

Descripción completa

Detalles Bibliográficos
Autores principales:	Maritsch, Friedrich, Cil, Ingeborg, McKinnon, Colin, Potash, Jesse, Baumgartner, Nicole, Philippon, Valérie, Pavlova, Borislava G.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2022
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9233846/ https://www.ncbi.nlm.nih.gov/pubmed/35752778 http://dx.doi.org/10.1186/s12910-022-00804-w

Ejemplares similares

Involvement of pharmaceutical companies at scientific meetings
por: Brink, Andries
Publicado: (2010)

Heterogeneity and Utility of Pharmaceutical Company Sharing of Individual-Participant Data Packages
por: Hopkins, Ashley M., et al.
Publicado: (2023)

Buyouts of Indian Pharmaceutical Companies by Multinational Pharmaceutical Companies: An Issue of Concern
por: Sreedhar, D, et al.
Publicado: (2011)

The influence of pharmaceutical companies
por: Migone, Paolo
Publicado: (2017)

Audit of Data Sharing by Pharmaceutical Companies for Anticancer Medicines Approved by the US Food and Drug Administration
por: Modi, Natansh D., et al.
Publicado: (2022)

Pharmaceutical Company Targets and Strategies to Address Climate Change: Content Analysis of Public Reports from 20 Pharmaceutical Companies
por: Booth, Amy, et al.
Publicado: (2023)

Pharmacovigilance in pharmaceutical companies: An overview
por: Mammì, Maria, et al.
Publicado: (2013)

Pharmacovigilance obligations of the pharmaceutical companies in India
por: Arora, Deepa
Publicado: (2008)

Regulating pharmaceutical companies’ financial largesse
por: Avraham, Ronen, et al.
Publicado: (2018)

The Pharmaceutical Company Approach to Antibiotic Policies
por: White, Anthony R.
Publicado: (2005)

Ethics, gastroenterologists, and pharmaceutical and equipment companies
por: Roberts‐Thomson, Ian C
Publicado: (2020)

Expected Impact of Biosimilars on the Pharmaceutical Companies
por: Golshani, Shiva, et al.
Publicado: (2021)

Medical Affairs in Pharmaceutical Companies and Related Pharmaceutical Regulations in Japan
por: Maeda, Hideki
Publicado: (2021)

Error in Payments From Some Pharmaceutical Companies
Publicado: (2019)

Unmet Medical Needs and the Role of Pharmaceutical Companies
por: Meyer-Sabellek, Wolfgang
Publicado: (2009)

Awareness of the implementation of the Falsified Medicines Directive among pharmaceutical companies’ professionals in the European Economic Area
por: WŁodarczak, Urszula, et al.
Publicado: (2017)

Public Health and Political Corporate Social Responsibility: Pharmaceutical Company Engagement in COVAX
por: Scholz, Markus, et al.
Publicado: (2023)

Challenges and key lessons from the design and implementation of an international haemophilia registry supported by a pharmaceutical company
por: Hay, Charles R. M., et al.
Publicado: (2020)

A 10-year update to the principles for clinical trial data sharing by pharmaceutical companies: perspectives based on a decade of literature and policies
por: Modi, Natansh D., et al.
Publicado: (2023)

Medical Journals Are an Extension of the Marketing Arm of Pharmaceutical Companies
por: Smith, Richard
Publicado: (2005)

Ten Simple Rules for Internship in a Pharmaceutical Company
por: Chen, Bin
Publicado: (2014)

Pharmaceutical companies as the funding sources for continuing medical education
por: Kanchan, Tanuj
Publicado: (2015)

Good Pharmacovigilance Practice: Accountability of Ayurvedic Pharmaceutical Companies
por: Sharma, Rohit, et al.
Publicado: (2017)

Are Pharmaceutical Company Payments Incentivising Malpractice in Japanese Physicians?
por: Kobashi, Yurie, et al.
Publicado: (2019)

The reasons behind medicine shortages from the perspective of pharmaceutical companies and pharmaceutical wholesalers in Finland
por: Heiskanen, Kati, et al.
Publicado: (2017)

Public health and corporate social responsibility: exploratory study on pharmaceutical companies in an emerging market
por: Dănescu, Tatiana, et al.
Publicado: (2020)

R&D Implementation in a Department of Laboratory Medicine and Pathology: A Systematic Review Based on Pharmaceutical Companies
por: Feulefack, Joseph, et al.
Publicado: (2015)

Managing robotics in the bioanalytical/metabolic environment of a pharmaceutical company
por: Kushinsky, Stanley
Publicado: (1991)

Personalized Medicine: Challenging Pharmaceutical and Diagnostic Company Business Models
por: Ferrara, Joseph
Publicado: (2007)

Regulation of Clinical Research Sponsored by Pharmaceutical Companies: A Proposal
por: Sotelo, Julio
Publicado: (2006)

A survey of pharmaceutical company representative interactions with doctors in Libya
por: Alssageer, Mustafa A., et al.
Publicado: (2012)

The Effect of Capital Structure on the Profitability of Pharmaceutical Companies The Case of Iran
por: Mohammadzadeh, Mehdi, et al.
Publicado: (2013)

Pharmaceutical company perspectives on current safety risk communications in Japan
por: Urushihara, Hisashi, et al.
Publicado: (2014)

Doctors’ opinions of information provided by Libyan pharmaceutical company representatives
por: Alssageer, Mustafa A., et al.
Publicado: (2012)

Good pharmacovigilance practice: Need of the hour from pharmaceutical companies
por: Bhati, Neha, et al.
Publicado: (2015)

Changing R&D models in research-based pharmaceutical companies
por: Schuhmacher, Alexander, et al.
Publicado: (2016)

The Role of Pharmaceutical Companies in Antimicrobial Stewardship: A Case Study
por: Hermsen, Elizabeth D, et al.
Publicado: (2020)

Strategic Patenting by Pharmaceutical Companies – Should Competition Law Intervene?
por: Gurgula, Olga
Publicado: (2020)

The optimization of overall equipment effectiveness factors in a pharmaceutical company
por: Chikwendu, Okpala Charles, et al.
Publicado: (2020)

Do companies in the pharmaceutical supply chain earn excess returns?
por: Sood, Neeraj, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_61j7esqqa05in15oifnfh79cf8